The Recall Desk

Manufacturer

Teva Pharmaceuticals USA

196 recalls in our database name Teva Pharmaceuticals USA as the manufacturing or recalling firm.

What the numbers show

Total
196
Critical
1
Severe
86
Most recent
2022-02-09

Of the 196 recalls from Teva Pharmaceuticals USA we have scored against our rubric, 1 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 86 (44%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

126–150 of 196

  • SevereFDA (Drugs)·D-0208-2018·2018-01-17

    Teva Recalls Moexipril Hydrochloride Tablets Due to Impurity Test Failure

    Teva Pharmaceuticals is recalling specific bottles of Moexipril Hydrochloride and Hydrochlorothiazide tablets because routine stability testing found high levels of a degradation impurity.

    Product
    Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed By: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5213-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0125-2018·2017-12-27

    Teva Recalls Amethyst Oral Contraceptive Tablets Due to Incorrect Labeling

    Teva Pharmaceuticals is recalling Amethyst oral contraceptive tablets because the packaging incorrectly states that Week 4 tablets are inactive, when all tablets are active.

    Product
    Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0108-2018·2017-12-20

    Teva Recalls Penicillin V Potassium Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling specific bottles of Penicillin V Potassium oral solution because they failed impurity and degradation specifications.

    Product
    PENICILLIN V POTASSIUM — PENICILLIN V POTASSIUM (PENICILLIN V POTASSIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0096-2018·2017-12-06

    Teva Recalls Clozapine Tablets Due to Potential Broken Tablets

    Teva Pharmaceuticals USA is recalling 3,870 bottles of Clozapine Tablets USP, 100 mg, due to failed specifications and potential broken tablets.

    Product
    Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0069-2018·2017-11-08

    Teva Recalls Dutasteride and Tamsulosin HCl Capsules for Dissolution Failures

    Teva Pharmaceuticals is recalling specific lots of Dutasteride and Tamsulosin HCl capsules because they failed dissolution specifications.

    Product
    Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippan
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0052-2018·2017-11-01

    Teva Recalls Methylphenidate Hydrochloride Tablets Due to Dissolution Failures

    Teva Pharmaceuticals USA is recalling 58,292 bottles of Methylphenidate Hydrochloride Tablets USP, 20 mg, because they failed to meet dissolution specifications.

    Product
    Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1178-2017·2017-10-04

    Teva Recalls Acarbose Tablets Due to Incorrect Expiration Date Labeling

    Teva Pharmaceuticals USA is recalling 3,275 bottles of Acarbose Tablets, 25 mg, because the product labeling displays an incorrect expiration date of July 2018 instead of the correct date of July 2017.

    Product
    Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1058-2017·2017-08-16

    Teva Recalls Glipizide Extended-Release Tablets Due to Moisture Limit Failures

    Teva Pharmaceuticals USA is recalling 2,880 cartons of Glipizide Extended-Release Tablets, 5 mg, because stability testing revealed out-of-specification water content.

    Product
    Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15
    Category
    Drug
    Distribution
    6 states
  • LowFDA (Drugs)·D-1039-2017·2017-08-09

    Teva Recalls Albuterol Sulfate Inhalation Solution Due to Impurities

    Teva Pharmaceuticals USA is recalling Albuterol Sulfate Inhalation Solution because high levels of a related compound were detected.

    Product
    Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0984-2017·2017-07-26

    Teva Recalls Buprenorphine and Naloxone Tablets Due to Impurities

    Teva Pharmaceuticals is recalling Buprenorphine and Naloxone Sublingual Tablets because test results showed out-of-specification impurities.

    Product
    Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0983-2017·2017-07-26

    Teva Recalls Buprenorphine and Naloxone Tablets Due to Impurities

    Teva Pharmaceuticals is recalling specific lots of Buprenorphine and Naloxone Sublingual Tablets because they failed impurity specifications.

    Product
    Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5720-56
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0705-2017·2017-05-17

    Teva Recalls Clozapine Tablets Due to Microbial Contamination

    Teva Pharmaceuticals is recalling specific lots of Clozapine Tablets USP, 25 mg, due to microbial contamination of non-sterile products.

    Product
    Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 977
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0703-2017·2017-05-17

    Teva Recalls Prednisolone Oral Solution for Failed Stability Specifications

    Teva Pharmaceuticals USA is recalling specific lots of Prednisolone Oral Solution because they failed stability specifications.

    Product
    PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0517-2017·2017-03-22

    Teva Recalls Buprenorphine and Naloxone Sublingual Tablets Due to Impurities

    Teva Pharmaceuticals is recalling specific lots of Buprenorphine and Naloxone Sublingual Tablets because they failed impurity and degradation specifications.

    Product
    Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0511-2017·2017-03-15

    Teva Recalls Risedronate Sodium Tablets Due to Dissolution Failures

    Teva Pharmaceuticals is recalling Risedronate Sodium Delayed-release Tablets because stability testing revealed low out-of-specification dissolution results.

    Product
    Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0479-2017·2017-02-22

    Teva Recalls Mimvey Lo Tablets Due to Impurity Test Failures

    Teva Pharmaceuticals USA is recalling specific lots of Mimvey Lo tablets because they failed impurity specifications for norethindrone.

    Product
    Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharm
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0440-2017·2017-02-01

    Teva Recalls Amoxicillin Oral Suspension Due to Low Potency

    Teva Pharmaceuticals is recalling specific lots of Amoxicillin for Oral Suspension because stability testing revealed the medication was below the required potency standard.

    Product
    Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0431-2017·2017-01-25

    Teva Recalls Risedronate Sodium Tablets for Failed Dissolution Specifications

    Teva Pharmaceuticals is recalling 6,800 cartons of Risedronate Sodium Delayed-release Tablets, 35 mg, because they failed dissolution specifications.

    Product
    Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0171-2017·2016-12-14

    Teva Recalls Qnasl Nasal Aerosol Due to Content Uniformity Failure

    Teva Pharmaceuticals USA is recalling Qnasl nasal aerosol because stability testing showed the product failed content uniformity specifications.

    Product
    Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0170-2017·2016-12-14

    Teva Recalls Qnasl Nasal Aerosol Due to Content Uniformity Failure

    Teva Pharmaceuticals is recalling Qnasl nasal aerosol canisters because the product failed stability testing for spray content uniformity.

    Product
    Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0111-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling specific lots of Paricalcitol Capsules because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 4 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7658-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0109-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling 32,015 bottles of Paricalcitol Capsules, 1 mcg, because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7656-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0110-2017·2016-10-26

    Teva Recalls Paricalcitol Capsules Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling 5,556 bottles of Paricalcitol Capsules because stability testing revealed out-of-specification impurities.

    Product
    PARICALCITOL Capsules, 2 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7657-56.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0023-2017·2016-10-19

    Teva Recalls Amikacin Sulfate Injection Due to Manufacturing Deviations

    Teva Pharmaceuticals USA is voluntarily recalling 27,547 vials of Amikacin Sulfate Injection due to CGMP deviations. The recall covers lots distributed nationwide and in Puerto Rico.

    Product
    Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials).
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Teva Pharmaceuticals CR

company in Prague, Czechia

Country
Czech Republic
Founded
1997

Official website

Source: Wikidata (Q41567143), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.